Cengild Medical Berhad Q1 2024 concluding on September 30, 2023, achieved a revenue of RM17.60 million. This marks a notable growth of RM1.83 million, equivalent to 11.62%, when juxtaposed with the preceding quarter concluding on June 30, 2023, which reported revenue of RM15.77 million.
DC Healthcare Holdings Berhad Q3-2023 interim financial report showing loss with higher administration expenses in this quarter amounting RM9.15 million. The substantial administrative expenses included one-off non-recurring listing expenses and consultancy fees related to the IPO exercise, amounting to RM3.85 million for the quarter under review.
Receive regular updates on Malaysia companies financial statements to stay informed about the latest developments and trends.
